Edwards Lifesciences (EW) VP exercises 619 options and sells 619 shares
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Daniel J. Lippis, CVP, TAVR, reported an option exercise and related stock sale. He exercised 619 Employee Stock Options at an exercise price of $72.68 per share, receiving 619 shares of Common Stock, and then sold 619 shares of Common Stock at $92.03 per share. Following the option exercise, he reported holding 4,333 options for Common Stock. The equity trades referencing the plan were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 619 shares ($12K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Lippis Daniel J.
Role
CVP, TAVR
Sold
619 shs ($57K)
Approx. gross sale proceeds
$57K
Approx. exercise cost
$45K
Approx. pre-tax spread
$12K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 619 | $72.68 | $45K |
| Sale | Common Stock F1 | 619 | $92.03 | $57K |
Holdings After Transaction:
Employee Stock Option (Right to Acquire) — 4,333 shares (Direct);
Common Stock — 40,033.9103 shares (Direct)
Footnotes (1)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.
Key Figures
Options Exercised: 619 shares
Exercise Price: $72.68 per share
Shares Sold: 619 shares
+3 more
6 metrics
Options Exercised
619 shares
Employee Stock Options exercised into Common Stock on 2026-08-11
Exercise Price
$72.68 per share
Exercise price of Employee Stock Options converted on 2026-08-11
Shares Sold
619 shares
Common Stock sold on 2026-08-11 in open market or private transaction
Sale Price
$92.03 per share
Price for Common Stock sale on 2026-08-11
Options Remaining
4,333 options
Total Employee Stock Options following the option exercise
Rule 10b5-1 Plan Adoption Date
February 13, 2026
Adoption date of trading plan governing the reported equity transactions
Key Terms
Rule 10b5-1 trading plan, Employee Stock Option, Exercise or conversion of derivative security, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"transactions were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option financial
"security title is listed as Employee Stock Option (Right to Acquire)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Exercise or conversion of derivative security financial
"transaction code M described as Exercise or conversion of derivative security"
beneficial ownership financial
"reflects changes in beneficial ownership only; it does not identify other"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Common Stock financial
"underlying security title and non-derivative security listed as Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transactions did Edwards Lifesciences (EW) report for Daniel J. Lippis?
Daniel J. Lippis exercised 619 stock options at $72.68 per share, acquired 619 shares of Common Stock, and sold 619 shares at $92.03 per share.
How many options does Daniel J. Lippis retain after this Form 4 at Edwards Lifesciences (EW)?
After the reported option exercise, Daniel J. Lippis holds 4,333 Employee Stock Options for Edwards Lifesciences Common Stock, as stated in the post-transaction holdings field for the derivative security.
Were the Edwards Lifesciences (EW) insider trades by Daniel J. Lippis under a Rule 10b5-1 plan?
Yes. The transactions in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Daniel J. Lippis on February 13, 2026, according to the footnote.
What role does Daniel J. Lippis hold at Edwards Lifesciences (EW) in this Form 4?
Daniel J. Lippis is identified as an officer of Edwards Lifesciences Corp with the title CVP, TAVR, indicating a corporate vice president position related to TAVR.
AI-generated analysis. How Rhea-AI works. Not financial advice.
